RIVASOL-HC SUPPOSITORIES 10 MG — DIN 02240112
ZINC SULFATE : 10 MG HYDROCORTISONE ACETATE : 10 MG · LABORATOIRE RIVA INC. · SUPPOSITORY · wholesale supply in Canada
Health Canada status: DORMANT
What is RIVASOL-HC SUPPOSITORIES?
RIVASOL-HC SUPPOSITORIES 10 MG contains ZINC SULFATE : 10 MG HYDROCORTISONE ACETATE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02240112, held by LABORATOIRE RIVA INC., supplied as SUPPOSITORY for RECTAL administration. Health Canada currently lists it as dormant, status dated 05-Jul-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Hydrocortisone cost around the world?
Hydrocortisone is listed on 15 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 11 | 71 | USD███.██ |
| South Africa | single exit price | 15 | 22 | ZAR███.██ |
| Saudi Arabia | public | 16 | 16 | SAR███.██ |
| Greece | producer price (ex-factory) | 15 | 15 | EUR███.██ |
| Austria | KVP (Kassenverkaufspreis) | 9 | 9 | EUR███.██ |
| Czechia | max producer price (ex-factory) | 5 | 9 | CZK███.██ |
| Australia | ex-manufacturer | 4 | 8 | AUD███.██ |
| United Arab Emirates | public | 4 | 6 | AED███.██ |
| Bahrain | retail (max) | 4 | 6 | BHD███.██ |
| Morocco | PPV (public price) | 5 | 6 | MAD███.██ |
| United Kingdom | hospital | 5 | 5 | GBP███.██ |
| Luxembourg | reimbursement | 4 | 4 | EUR███.██ |
| Iceland | max wholesale | 3 | 3 | ISK███.██ |
| Norway | max AUP (pharmacy retail) | 2 | 2 | NOK███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
183 pack listings across 103 brand entries and 14 price bases, refreshed 10 Sep 2026. Ranges span every Hydrocortisone pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Hydrocortisone in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
13 holders have a Canadian DIN containing Hydrocortisone, across 32 DINs, of which 10 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| ODAN LABORATORIES LTD | 7 | 6 | ANODAN-HC 10MG SUPPOSITORIES, ANODAN-HC OINTMENT, ODAN PROCTOMYXIN HC, PROCTODAN-HC OINTMENT, PROCTODAN-HC SUPPOSITORIES, +2 more | Sourceable in Canada |
| CHURCH & DWIGHT CANADA CORP | 2 | 2 | ANUSOL-HC OINTMENT, ANUSOL-HC SUPPOSITORIES | Sourceable in Canada |
| TEVA CANADA LIMITED | 4 | 1 | RATIO-HEMCORT-HC, TEVA-PROCTOSONE | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 1 | 1 | JAMPZINC-HC | Sourceable in Canada |
| LABORATOIRE RIVA INC. | 3 | 0 | RECTOGEL HC, RIVA-SOL HC OINTMENT, RIVASOL-HC SUPPOSITORIES | No marketed DIN |
| APTALIS PHARMA CANADA ULC | 2 | 0 | PROCTOSEDYL | No marketed DIN |
| HOECHST ROUSSEL CANADA INC. | 2 | 0 | PROCTOSEDYL OINTMENT, PROCTOSEDYL SUPPOSITORIES | No marketed DIN |
| PHARMASCIENCE INC | 2 | 0 | EGOZINC-HC | No marketed DIN |
| ROUSSEL CANADA INC. | 2 | 0 | PROCTOSEDYL OINTMENT, PROCTOSEDYL SUP | No marketed DIN |
| SANDOZ CANADA INCORPORATED | 2 | 0 | SANDOZ ANUZINC HC, SANDOZ ANUZINC HC PLUS | No marketed DIN |
| TECHNILAB PHARMA INC. | 2 | 0 | PROCTOSONE ONT, PROCTOSONE SUP | No marketed DIN |
| WELCKER-LYSTER LTD., DIVISION OF TECHNILAB INC. | 2 | 0 | RECTOCORT ONT, RECTOCORT SUP | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 10 MG |
|---|---|
| Dosage form | SUPPOSITORY |
| Route | RECTAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Hydrocortisone |
|---|---|
| ATC code | C05AA01 |
| AHFS class | 84:06.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02240112 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2240112 |
| Brand name | RIVASOL-HC SUPPOSITORIES |
| Generic / active ingredient | ZINC SULFATE : 10 MG HYDROCORTISONE ACETATE : 10 MG |
| Market authorization holder | LABORATOIRE RIVA INC. |
| Health Canada schedule | Prescription |
| ATC code | C05AA01 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C05AA |
| Current status | DORMANT |
| Status date | 05-Jul-2017 |
| Original market date | 1999-05-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
10 of 32 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ANODAN-HC 10MG SUPPOSITORIES | 10 MG | SUPPOSITORY | ODAN LABORATORIES LTD | MARKETED | 02236399 |
| ANODAN-HC OINTMENT | 0.5 % | OINTMENT | ODAN LABORATORIES LTD | MARKETED | 02128446 |
| ANUSOL-HC OINTMENT | 0.5 % | OINTMENT | CHURCH & DWIGHT CANADA CORP | MARKETED | 00505773 |
| ANUSOL-HC SUPPOSITORIES | 10 MG | SUPPOSITORY | CHURCH & DWIGHT CANADA CORP | MARKETED | 00476285 |
| JAMPZINC-HC | 0.5 % | OINTMENT | JAMP PHARMA CORPORATION | MARKETED | 02387239 |
| PROCTODAN-HC OINTMENT | 1 % | OINTMENT | ODAN LABORATORIES LTD | MARKETED | 02234466 |
| PROCTODAN-HC SUPPOSITORIES | 10 MG | SUPPOSITORY | ODAN LABORATORIES LTD | MARKETED | 02240851 |
| PROCTOL OINTMENT | 0.5 % | OINTMENT | ODAN LABORATORIES LTD | MARKETED | 02247322 |
| PROCTOL SUPPOSITORIES | 10 MG | SUPPOSITORY | ODAN LABORATORIES LTD | MARKETED | 02247882 |
| TEVA-PROCTOSONE | 1 % | OINTMENT | TEVA CANADA LIMITED | MARKETED | 02226383 |
2 · Same class — other molecules in ATC C05AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Hydrocortisone | ANODAN-HC 10MG SUPPOSITORIES · ANODAN-HC OINTMENT · ANUSOL-HC OINTMENT · ANUSOL-HC SUPPOSITORIES · +23 more | 32 | 10 | Yes |
| Hydrocortisone, Combinations | ANUGESIC-HC OINTMENT · ANUGESIC-HC SUPPOSITORIES · ANUZINC HC · ANUZINC HC PLUS · +1 more | 5 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC C05A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| C05AD | Anesthetics, Combinations · Benzocaine · Cinchocaine · Lidocaine · Pramocaine · +1 more | 23 | 3 |
| C05AX | Other Agents For Treatment Of Hemorrhoids And Anal Fissures For Topical Use · Other Preparations, Combinations · Zinc Preparations | 20 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is RIVASOL-HC SUPPOSITORIES called?
The same molecule, Hydrocortisone, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Alfacort | Latin | Bahrain, Saudi Arabia, United Arab Emirates |
| HYDROCORTISON VUAB | Latin | Czechia |
| Dilucort | Latin | South Africa |
| HYDROCORTISONE LEURQUIN | Latin | Morocco |
| Macleods Hydrocortisone Injection | Latin | South Africa |
| Softacort | Latin | Czechia, Iceland |
| Terracortril | Latin | South Africa |
| Acecort | Latin | Norway |
| CANDICORT CREAM | Latin | Saudi Arabia |
| COLIRCUSI H.C WITH NEOM | Latin | Saudi Arabia |
| CORTIDERM | Latin | Bahrain |
| Cortotic Vet | Latin | Iceland |
| Covocort | Latin | South Africa |
| Daktacort | Latin | South Africa |
| EFFICORT HYDROPHILE | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Hydrocortisone called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Hydrocortisone, published to help those searches reach this page.
| Language | Hydrocortisone |
|---|---|
| Arabic العربية | هيدروكورتيزون |
| Chinese (Simplified) 简体中文 | 氢化可的松 |
| Russian Русский | гидрокортизон |
| Spanish Español | hidrocortisona |
| Portuguese Português | hidrocortisona |
| German Deutsch | Hydrocortison |
| Japanese 日本語 | ヒドロコルチゾン |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.